临床试验 6

• CHMP建议欧盟批准达罗鲁米特加ADT用于mHSPC 2025/06/20
• Phase 3 trial launches of ifinatamab deruxtecan vs chemotherapy in mCRPC 2025/06/18
• Khurshid Ghani，MBChB，MS，FRCS，谈当前支架遗漏的障碍 2025/06/17
• 不同mHSPC人群中剩余未满足的需求 2025/06/16
• Improving diversity in future clinical trials for mHSPC 2025/06/16
• FDA批准Anktiva扩大使用计划治疗淋巴细胞减少症 2025/06/07